[Translation] A randomized, double-blind, double-mock, phase III clinical study to evaluate the efficacy and safety of TAK-438 compared with lansoprazole in subjects with duodenal ulcers
主要目的:评估TAK-438相比兰索拉唑治疗十二指肠溃疡受试者的非劣效性。 次要目的:评估TAK-438相比兰索拉唑对HP根除治疗的非劣效性。比较TAK-438 与兰索拉唑在十二指肠溃疡受试者中的安全性。
[Translation] Main objective: To evaluate the non-inferiority of TAK-438 compared to lansoprazole in subjects with duodenal ulcer. Secondary objective: To evaluate the non-inferiority of TAK-438 compared to lansoprazole for HP eradication therapy. To compare the safety of TAK-438 with lansoprazole in subjects with duodenal ulcer.